Tissue Substitution refers to the replacement of damaged or lost biological tissues with synthetic or bioengineered alternatives. This approach is employed when the body's natural regenerative capacity is insufficient for complete tissue repair. Tissue substitution strategies include the use of implants, grafts, or tissue-engineered constructs designed to mimic the structure and function of the native tissue. Examples include joint prostheses in orthopedics, artificial heart valves in cardiovascular surgery, and synthetic skin grafts for treating severe burns. Advances in biomaterials and tissue engineering have expanded the possibilities for tissue substitution, aiming to provide more effective and long-lasting solutions. Biocompatible materials, such as polymers or ceramics, are often used to create implants that integrate seamlessly with the surrounding tissues. Tissue engineering techniques involve the fabrication of complex, living constructs that promote host tissue integration and regeneration. The success of tissue substitution relies on the compatibility of materials, proper surgical techniques, and the ability of the substitute to withstand mechanical forces and biological interactions within the body. Ongoing research in tissue substitution focuses on improving biomaterial properties, enhancing biointegration, and expanding the range of tissues that can be effectively substituted, contributing to advancements in regenerative medicine and personalized healthcare.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States